Protocols
3 protocol(s) meet the specified criteria
Drug: IPILIMUMAB
Protocol No.TitleStatus
ECOG1609-CIRBA Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Vs High Dose Interferon alpha2b for Resected High-Risk Melanoma Open (affiliates only)
GO29322A Phase Ib Study of the Safety and Pharmacology of Atezolizumab (Anti-PD-L1 Antibody) Administered with Ipilimumab, Interferon-Alpha, or Other Immune-Modulating Therapies in Patients with Locally Advanced or Metastatic Solid TumorsOpen
S1404-CIRB-MK-3475-053S1404: A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma Open